Abstract
A new pharmacological inhibitor of the Cdc7 protein kinase can block replication initiation without activating the replication checkpoint, thus validating replication initiation as a new target class for cancer cell chemotherapy.
- Title
- Stopping replication, at the beginning
- Creators - without role
- Peter K. Jackson - Stanford UniversityPeter Lawrence Jackson - ESD Pillar
- Publication Details
- Nature chemical biology, Vol.4(6), pp.331-332
- Publisher
- Springer Nature
- Number of pages
- 2
- Identifiers
- 9912739709846
- Academic Unit
- ESD Pillar
- Language
- English
- Resource Type
- Journal article